The immunostimulant RU41740 from Klebsiella pneumoniae activates human cells in whole blood to potentially stimulate innate and adaptive immune responses

International Immunopharmacology

Volumn 6, Issue 4, 2006, Pages 635-646

  Pedraza Sánchez, Sigifredo ^a   González Hernández, Yolanda ^a   Escobar Gutiérrez, Alejandro ^a   Ramachandra, Lakshmi ^b,c  

^a Instituto Nacional de Diagnostico y Referencia Epidemiologicos   (Mexico)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Biostim; Cell activation; Immunostimulant; Innate immunity; K. pneumoniae; Monocytes; NK cells; RU41740

Indexed keywords

B7 ANTIGEN; BIOSTIM; CD69 ANTIGEN; CD86 ANTIGEN; CELL MARKER; CYTOKINE; GAMMA INTERFERON; HLA DR ANTIGEN; IMMUNOSTIMULATING AGENT; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; POLYMYXIN B; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; BLOOD; BLOOD SAMPLING; CELL ACTIVATION; CELL LEVEL; CONTAMINATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPHARMACOLOGY; IMMUNOSTIMULATION; IN VITRO STUDY; INCUBATION TIME; INFLAMMATION; INNATE IMMUNITY; KLEBSIELLA PNEUMONIAE; LEUKOCYTE ACTIVATION; MALE; MONOCYTE; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; T LYMPHOCYTE; UPREGULATION;

ADJUVANTS, IMMUNOLOGIC; ADULT; ANTI-BACTERIAL AGENTS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; B-LYMPHOCYTES; BACTERIAL PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; IMMUNITY, CELLULAR; INTERLEUKIN-6; KILLER CELLS, NATURAL; KLEBSIELLA PNEUMONIAE; LEUKOCYTES; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; POLYMYXIN B; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33644559965     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2005.10.006     Document Type: Article

References (33)

1. S. Uthaisangsook, N.K. Day, S.L. Bahna, R.A. Good, and S. Haraguchi Innate immunity its role against infections Ann Allergy Asthma Immunol 88 2002 253 264 [quiz 265-256, 318]
2. S. Akira Toll-like receptors and innate immunity Adv Immunol 78 2001 1 56
3. K. Takeda, T. Kaisho, and S. Akira Toll-like receptors Annu Rev Immunol 21 2003 335 376
4. R. Medzhitov Toll-like receptors and innate immunity Nat Rev Immunol 1 2001 135 145
5. M. Guebre-Xabier, S.A. Hammond, L.R. Ellingsworth, and G.M. Glenn Immunostimulant patch enhances immune responses to influenza virus vaccine in aged mice J Virol 78 2004 7610 7618
6. A. Molinaro, R. Lanzetta, A. Mancino, A. Evidente, M. Di Rosa, and A. Ianaro Immunostimulant (1- > 3)-D-glucans from the cell wall of Cryphonectria parasitica (Murr.) Barr strain 263 Carbohydr Res 329 2000 441 445
7. V. Lakshmi, K. Pandey, A. Puri, R.P. Saxena, and K.C. Saxena Immunostimulant principles from Curculigo orchioides J Ethnopharmacol 89 2003 181 184
8. P. Smets, M.F. Salles, M. Rommain, R. Zalisz, M. Yagello, and M. Guenounou RU-41740 (K. pneumoniae glycoprotein) enhances resistance to experimental candidiasis and stimulates phagocytic functions Ann Inst Pasteur Immunol 138 1987 425 436
9. H. Nielsen Augmentation of human blood monocyte microbicidal activity by RU 41740, a glycoprotein extract from Klebsiella pneumoniae Eur J Clin Pharmacol 30 1986 99 104
10. S. Sozzani, F. D'Alessandro, F. Capsoni, W. Luini, W. Barcellini, and G. Guidi In vitro modulation of human monocytes functions by RU 41740 (Biostim) Int J Immunopharmacol 10 1988 93 102
11. K. Nimier, F. Wolff, P.Y. Allouch, D. Guy-Gr, and C. Bloy Protective effects of RU 41740 a bacterial immunomodulator, against experimental infections: induction of cytokine and immunoglobulin release in mice after oral administration Int J Immunopharmacol 21 1999 561 574
12. A. Fietta, C. Bersani, V. De Rose, P. Mangiarotti, C. Merlini, and M. Uccelli Double-blind trial RU 41740 vs. placebo: immunological and clinical effects in a group of patients with chronic bronchitis Respiration 54 1988 145 152
13. A.M. Fietta, C. Merlini, M. Uccelli, G. Gialdroni Grassi, and C. Grassi Immunological clinical effect of long-term oral treatment with RU 41740 in patients with chronic bronchitis: double-blind trial long-term versus standard dose regimen Respiration 59 1992 253 258
14. J. Estaquier, C. Bloy, F. Corallo, C. Peron, and J.C. Ameisen The immunomodulating glycoprotein extract from Klebsiella pneumoniae RU 41740 exerts a suppressive effect on human monocyte death by apoptosis Immunopharmacology 39 1998 157 164
15. R. Spisek, J. Brazova, D. Rozkova, K. Zapletalova, A. Sediva, and J. Bartunkova Maturation of dendritic cells by bacterial immunomodulators Vaccine 22 2004 2761 2768
16. A. Kol, A.H. Lichtman, R.W. Finberg, P. Libby, and E.A. Kurt-Jones Cutting edge: heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells J Immunol 164 2000 13 17
17. C. Prussin, and D.D. Metcalfe Detection of intracytoplasmic cytokine using flow cytometry directly conjugated anti-cytokine antibodies J Immunol Methods 188 1995 117 128
18. S.F. Ziegler, F. Ramsdell, and M.R. Alderson The activation antigen CD69 Stem Cells 12 1994 456 465
19. J. Bradshaw Cationic antimicrobial peptides: issues for potential clinical use BioDrugs 17 2003 233 240
20. J.P. Andreux, M. Renard, M.H. Andreux, and P. Smets Modulation of murine hemopoiesis by repeated injections of a glycoprotein extract from Klebsiella pneumoniae Int J Immunopharmacol 8 1986 147 154
21. H. Blomgren Influence of RU 41.740 on human monocytes in vitro: release of soluble factors which retard multiplication of tumor cells in culture Int J Immunopharmacol 12 1990 99 105
22. C. Griscelli, B. Grospierre, J. Montreuil, B. Fournet, G. Bruvier, and J.M. Lang Immunomodulation by glycoprotein fractions isolated from K. pneumoniae Y. Yamamura Immunomodulation by microbial products and related synthetic compounds 1982 Excerpta Medica Amsterdam 261 265
23. M. Guenounou, F. Vacheron, C. Nauciel, and J. Agneray Induction of interleukin 1 secretion by murine macrophages human monocytes after stimulation by RU 41740, a bacterial immunomodulator Int J Immunopharmacol 7 1985 287 290
24. B. de Wazieres, V. Spehner, S. Harraga, F. Laplante, F. Corallo, and C. Bloy Alteration in the production of free oxygen radicals and proinflammatory cytokines by peritoneal and alveolar macrophages in old mice and immunomodulatory effect of RU 41740 administration: Part I. Effect of short and repetitive noise stress Immunopharmacology 39 1998 51 59
25. C. Meredith, M.P. Scott, H. Pekelharing, and K. Miller The effect of Biostim (RU-41740) on the expression of cytokine mRNAs in murine peritoneal macrophages in vitro Toxicol Lett 53 1990 327 337
26. J. Bonde, R. Dahl, R. Edelstein, A. Kok-Jensen, L. Lazer, and L. Punakivi The effect of RU 41.740, an immune modulating compound, in the prevention of acute exacerbations in patients with chronic bronchitis Eur J Respir Dis 69 1986 235 241
27. G. Bellon, and I. Ounis The preventive treatment of recurring respiratory infections using RU 41740 in 3,008 children Ann Pediatr (Paris) 37 1990 535 540
28. M.L. Profeta, G. Guidi, P.L. Meroni, R. Palmieri, G. Palladino, and V. Cantone Influenza vaccination with adjuvant RU41740 in the elderly Lancet 1 1987 973
29. S. Sozzani, W. Luini, L. Braceschi, and F. Spreafico The effect of Biostim (RU 41.740) on natural killer activity in different mouse organs Int J Immunopharmacol 8 1986 845 853
30. G. Migliorati, G. Guidi, L. Cannarile, and C. Riccardi Effect of Biostim (RU 41.740) on natural killer cell generation from bone marrow precursors Int J Immunopharmacol 11 1989 77 82
31. C.D. Wood, and G. Moller Influence of RU 41.740, a glycoprotein extract from Klebsiella pneumoniae, on the murine immune system: I. T-independent polyclonal B cell activation J Immunol 132 1984 616 621
32. A. Durandy, P. Smets, R. Zalisz, and C. Griscelli The effect of RU 41740 on the in vitro maturation of human B-cells Int J Immunopharmacol 10 1988 851 854
33. A. Chalifour, P. Jeannin, J.F. Gauchat, A. Blaecke, M. Malissard, and T. N'Guyen Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production Blood 104 2004 1778 1783